論文 - 詳細
| RRC ID | 64118 |
|---|---|
| 著者 | Shoji T, Saito R, Chonan M, Shibahara I, Sato A, Kanamori M, Sonoda Y, Kondo T, Ishii N, Tominaga T. |
| タイトル | Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models. |
| ジャーナル | Neuro Oncol |
| Abstract |
BACKGROUND:Glioblastoma is one of the most malignant brain tumors in adults and has a dismal prognosis. In a previous report, we reported that CD40, a TNF-R-related cell surface receptor, and its ligand CD40L were associated with glioma outcomes. Here we attempted to activate CD40 signaling in the tumor and determine if it exerted therapeutic efficacy. METHODS:CD40 expression was examined in 3 mouse glioma cell lines (GL261, NSCL61, and bRiTs-G3) and 5 human glioma cell lines (U87, U251, U373, T98, and A172). NSCL61 and bRiTs-G3, as glioma stem cells, also expressed the glioma stem cell markers MELK and CD44. In vitro, we demonstrated direct antitumor effects of an anti-CD40 agonistic monoclonal antibody (FGK45) against the cell lines. The efficacy of FGK45 was examined by local convection-enhanced delivery of the monoclonal antibody against each glioma model. RESULTS:CD40 was expressed in all mouse and human cell lines tested and was found at the cell membrane of each of the 3 mouse cell lines. FGK45 administration induced significant, direct antitumor effects in vitro. The local delivery of FGK45 significantly prolonged survival compared with controls in the NSCL61 and bRiTs-G3 models, but the effect was not significant in the GL261 model. Increases in apoptosis and CD4(+) and CD8(+) T cell infiltration were observed in the bRiTs-G3 model after FGK45 treatment. CONCLUSIONS:Local delivery of FGK45 significantly prolonged survival in glioma stem cell models. Thus, local delivery of this monoclonal antibody is promising for immunotherapy against gliomas. |
| 巻・号 | 18(8) |
| ページ | 1120-8 |
| 公開日 | 2016-8-1 |
| DOI | 10.1093/neuonc/now023 |
| PII | now023 |
| PMID | 26917236 |
| PMC | PMC4933484 |
| MeSH | Animals Antibodies, Monoclonal / administration & dosage* Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / administration & dosage* Antineoplastic Agents / therapeutic use Apoptosis / drug effects Brain / drug effects Brain Neoplasms / drug therapy* Brain Neoplasms / immunology Brain Neoplasms / metabolism CD40 Antigens / agonists* CD40 Antigens / immunology CD40 Antigens / metabolism CD40 Antigens / therapeutic use Cell Line, Tumor Convection Disease Models, Animal Female Glioma / drug therapy* Glioma / immunology Glioma / metabolism Humans Immunotherapy / methods* Mice Mice, Inbred C57BL Survival Analysis Vaccination / methods |
| IF | 10.247 |
| リソース情報 | |
| ヒト・動物細胞 | A172(RCB2530) |